{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:14:55Z","timestamp":1781806495266,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2015B090903063"],"award-info":[{"award-number":["2015B090903063"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2017A020215075"],"award-info":[{"award-number":["2017A020215075"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bbrc.2019.04.099","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T17:01:43Z","timestamp":1556211703000},"page":"295-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeting \u03b23-adrenergic receptor signaling inhibits neuroblastoma cell growth via suppressing the mTOR pathway"],"prefix":"10.1016","volume":"514","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-2032","authenticated-orcid":false,"given":"Jing","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3009-4074","authenticated-orcid":false,"given":"Zhonghan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.04.099_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.phrs.2018.02.023","article-title":"Molecular mechanisms and therapeutic targets in neuroblastoma","volume":"131","author":"Johnsen","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2019.04.099_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.24659","article-title":"The \u201cneuro\u201d of neuroblastoma: neuroblastoma as a neurodevelopmental disorder","volume":"80","author":"Ratner","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2019.04.099_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2019.04.099_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semcancer.2011.07.002","article-title":"Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research","volume":"21","author":"Ora","year":"2011","journal-title":"Semin. Canc. Biol."},{"key":"10.1016\/j.bbrc.2019.04.099_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.critrevonc.2016.10.001","article-title":"Neuroblastoma (Peripheral neuroblastic tumours)","volume":"107","author":"Luksch","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2019.04.099_bib6","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00247-018-4117-9","article-title":"A\u00a0review of neuroblastoma image-defined risk factors on magnetic resonance imaging","volume":"48","author":"Chen","year":"2018","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.bbrc.2019.04.099_bib7","article-title":"ALK and GSK3: shared features of neuroblastoma and neural crest cells","volume":"12","author":"Gonzalez Malagon","year":"2018","journal-title":"J.\u00a0Exp. Neurosci."},{"key":"10.1016\/j.bbrc.2019.04.099_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.354","article-title":"Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis","volume":"6","author":"Nicolai","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2019.04.099_bib9","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1002\/cncr.30873","article-title":"Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: a report from the Children's Oncology Group","volume":"123","author":"Campbell","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2019.04.099_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/gcc.22398","article-title":"Heterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis","volume":"56","author":"Marrano","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbrc.2019.04.099_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.sempedsurg.2011.10.009","article-title":"Neuroblastoma","volume":"21","author":"Davidoff","year":"2012","journal-title":"Semin. Pediatr. Surg."},{"key":"10.1016\/j.bbrc.2019.04.099_bib12","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bbrc.2019.04.099_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/5584_2016_36","article-title":"The role of beta-blockers in the treatment of hypertension","volume":"956","author":"Cruickshank","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2019.04.099_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2015.tb00599.x","article-title":"Peripheral and central effects of circulating catecholamines","volume":"5","author":"Tank","year":"2015","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.bbrc.2019.04.099_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1188\/14.ONF.533-540","article-title":"State of the science: stress, inflammation, and cancer","volume":"41","author":"Payne","year":"2014","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.bbrc.2019.04.099_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pharmthera.2005.04.006","article-title":"Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling","volume":"108","author":"Zheng","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2019.04.099_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbrc.2013.07.055","article-title":"Nebivolol stimulates mitochondrial biogenesis in 3T3-L1 adipocytes","volume":"438","author":"Huang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2019.04.099_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s001250051341","article-title":"New insights into sympathetic regulation of glucose and fat metabolism","volume":"43","author":"Nonogaki","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2019.04.099_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jhep.2016.04.019","article-title":"ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1alpha","volume":"65","author":"Wu","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2019.04.099_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/mutage\/geu045","article-title":"The expanding role of mTOR in cancer cell growth and proliferation","volume":"30","author":"Cargnello","year":"2015","journal-title":"Mutagenesis"},{"key":"10.1016\/j.bbrc.2019.04.099_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2015.11.011","article-title":"Recent advances in adipose mTOR signaling and function: therapeutic prospects","volume":"37","author":"Cai","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2019.04.099_bib22","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1245\/s10434-012-2396-1","article-title":"The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection","volume":"19","author":"Chen","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbrc.2019.04.099_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0655-3","article-title":"\u03b22-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion","volume":"17","author":"Creed","year":"2015","journal-title":"Breast Canc. Res."},{"key":"10.1016\/j.bbrc.2019.04.099_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/138920311795659407","article-title":"Role of mTOR signaling in tumor cell motility, invasion and metastasis","volume":"12","author":"Zhou","year":"2011","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbrc.2019.04.099_bib25","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1158\/1535-7163.MCT-14-0147","article-title":"Delineating the mTOR kinase pathway using a dual TORC1\/2 inhibitor, AZD8055, in multiple myeloma","volume":"13","author":"Cirstea","year":"2014","journal-title":"Mol. Canc. Therapeut."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19307417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19307417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:18:54Z","timestamp":1770830334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19307417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0006291X19307417"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.099","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting \u03b23-adrenergic receptor signaling inhibits neuroblastoma cell growth via suppressing the mTOR pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}